Management of hypertension and dyslipidemia in Mexico: evidence, gaps, and approach

por Morales-Villegas, Enrique C., Yarleque, Carlos, Almeida, María L.
Publicado 2023

Statins: Cardiovascular Risk Reduction in Percutaneous Coronary Intervention—Basic and Clinical Evidence of Hyperacute Use of Statins

por Morales-Villegas, Enrique C., Di Sciascio, Germano, Briguori, Carlo
Publicado 2011

A Relative Cost of Control Analysis of IDegLira versus Other Forms of Basal Insulin Intensification in Mexico

por Garnica-Cuellar, Juan Carlos, Morales-Villegas, Enrique, López-Forero, Carmen Alicia, Monroy-Cruz, Bárbara, Pariti, Bhrugu, Deshwal, Swati, Sekharan, Manisha, Osorio-Hernández, Mariana, García-Appendini, Ida Caterina
Publicado 2023

Risk stratification and lipid evaluation in mexican patients, evidence of lipid and cardiovascular analysis in REMECAR. The mexican registry of cardiovascular diseases (REMECAR gro...

por De los Ríos-Ibarra, Manuel Odín, Leiva-Pons, José Luis, Rodríguez-Reyes, Humberto, Alcocer-Gamba, Marco Antonio, Cortés-Lawrenz, Jorge, Vizcaíno-Rios, Frida María, Barragán-Luna, Jaime, Farjat-Ruiz, Julio Iván, Virgen-Carrillo, Luis R., Padilla-Padilla, Francisco, Pavia-López, Abel, Morales-Villegas, Enrique C., Ward, Natalie C., Lugo-Gavidia, Leslie Marisol
Publicado 2022